Study of OTO-104 in Subjects With Unilateral Meniere's Disease
Completed · Phase 3 · Has a placebo group
Conditions studied: Meniere's Disease
In brief
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
Key facts
- Study ID
- NCT02612337
- Run by
- Otonomy, Inc.
- People needed
- 166
- Starts
- 2015-10-27
- Expected to finish
- 2017-07-18
- Last updated by the study team
- 2023-01-12
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Many sites in US. Refer to the contact info listed below. — San Diego, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.